DEUTSCHE BANK AG\ - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 50 filers reported holding VINCERX PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q1 2022$41,000
-64.0%
10,054
-9.5%
0.00%
Q4 2021$114,000
-5.8%
11,114
+48.1%
0.00%
Q3 2021$121,000
+236.1%
7,504
+168.7%
0.00%
Q2 2021$36,0002,7930.00%
Other shareholders
VINCERX PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,618,199$31,231,00010.26%
Affinity Asset Advisors, LLC 543,010$10,480,0003.56%
ACUTA CAPITAL PARTNERS, LLC 394,000$7,604,0002.74%
TANG CAPITAL MANAGEMENT LLC 500,000$9,650,0002.72%
Logos Global Management LP 480,000$9,264,0000.90%
Sio Capital Management, LLC 105,000$2,027,0000.41%
SABBY MANAGEMENT, LLC 82,948$1,601,0000.31%
Monashee Investment Management LLC 99,999$1,930,0000.30%
Ikarian Capital, LLC 438,684$8,467,0000.28%
RTW INVESTMENTS, LP 500,000$9,650,0000.15%
View complete list of VINCERX PHARMA INC shareholders